Drug discovery: lessons from evolution
نویسندگان
چکیده
منابع مشابه
Magnetic resonance imaging in drug discovery: lessons from disease areas.
Imaging technologies are presently receiving considerable attention in the pharmaceutical area owing to their potential to accelerate the drug discovery and development process. One of the principal imaging modalities is magnetic resonance imaging (MRI). The multiparametric nature of MRI enables anatomical, functional and even molecular information to be obtained non-invasively from intact orga...
متن کاملEthnobotany, Ethnopharmacology and Drug Discovery
This manuscript is a review of a number of ethnobotany and ethnopharmacology texts and papers in order to arrive at current understanding and scope of ethnobotany and ethnopharmacology. It includes either a brief definition of both fields and presenting some examples on them. Also it has a glimpse on the geographical coverage of research works throughout the world, important issue of prope...
متن کاملLinked Biomedical Dataspace: Lessons Learned Integrating Data for Drug Discovery
The increase in the volume and heterogeneity of biomedical data sources has motivated researchers to embrace Linked Data (LD) technologies to solve the ensuing integration challenges and enhance information discovery. As an integral part of the EU GRANATUM project, a Linked Biomedical Dataspace (LBDS) was developed to semantically interlink data from multiple sources and augment the design of i...
متن کاملThe Evolution of Long-term Care Programs; Comment on “Financing Long-term Care: Lessons From Japan”
The need for long-term care (LTC) represents a “new social risk,” one that overlaps with and complements systems of care that pre-date such programs, complicating LTC program design. This commentary expands on Ikegami’s discussion of how these structural factors must be accommodated, as well as historical and cultural factors that influence public expectations of such a...
متن کاملFrom discovery to the clinic: lessons learned.
Universities are great settings for discovery but have very weak infrastructures for further therapy development. There is no real university–industry integrated model that has been successful in the translation of science into disease therapy. Instead, the process seems dependent on chance relationships and, often, the fortuitous presence of “champions.” A new strategic plan is needed to promo...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Clinical Pharmacology
سال: 2011
ISSN: 0306-5251
DOI: 10.1111/j.1365-2125.2010.03854.x